Sonnet Biotherapeutics Holdings Stock Price History

SONN Stock  USD 1.36  0.04  2.86%   
Below is the normalized historical share price chart for Sonnet Biotherapeutics Holdings extending back to July 27, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sonnet Biotherapeutics stands at 1.36, as last reported on the 27th of March, with the highest price reaching 1.41 and the lowest price hitting 1.33 during the day.
IPO Date
31st of October 2006
200 Day MA
4.4803
50 Day MA
1.5306
Beta
1.01
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Sonnet Stock, it is important to understand the factors that can impact its price. Sonnet Biotherapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of close to zero, which indicates the firm had a close to zero % return per unit of risk over the last 3 months. Sonnet Biotherapeutics Holdings exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sonnet Biotherapeutics' Risk Adjusted Performance of (0.02), variance of 31.81, and Coefficient Of Variation of (2,718) to confirm the risk estimate we provide.
  
At this time, Sonnet Biotherapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 27th of March 2025, Stock Based Compensation To Revenue is likely to grow to 11.73, while Liabilities And Stockholders Equity is likely to drop about 28.3 M. . As of the 27th of March 2025, Price To Sales Ratio is likely to drop to 2.24. In addition to that, Price Earnings Ratio is likely to drop to -11.11. Sonnet Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.004

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSONN

Estimated Market Risk

 5.73
  actual daily
51
51% of assets are less volatile

Expected Return

 -0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.0
  actual daily
0
Most of other assets perform better
Based on monthly moving average Sonnet Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sonnet Biotherapeutics by adding Sonnet Biotherapeutics to a well-diversified portfolio.
Price Book
1.0101
Enterprise Value Ebitda
(0.21)
Price Sales
4.1694
Shares Float
M
Wall Street Target Price
160

Sonnet Biotherapeutics Stock Price History Chart

There are several ways to analyze Sonnet Stock price data. The simplest method is using a basic Sonnet candlestick price chart, which shows Sonnet Biotherapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 22, 20252.0
Lowest PriceMarch 13, 20251.32

Sonnet Biotherapeutics March 27, 2025 Stock Price Synopsis

Various analyses of Sonnet Biotherapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sonnet Stock. It can be used to describe the percentage change in the price of Sonnet Biotherapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sonnet Stock.
Sonnet Biotherapeutics Price Daily Balance Of Power(0.50)
Sonnet Biotherapeutics Price Action Indicator(0.03)
Sonnet Biotherapeutics Price Rate Of Daily Change 0.97 

Sonnet Biotherapeutics March 27, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Sonnet Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Sonnet Biotherapeutics intraday prices and daily technical indicators to check the level of noise trading in Sonnet Stock and then apply it to test your longer-term investment strategies against Sonnet.

Sonnet Stock Price History Data

The price series of Sonnet Biotherapeutics for the period between Fri, Dec 27, 2024 and Thu, Mar 27, 2025 has a statistical range of 0.68 with a coefficient of variation of 8.79. The price distribution for the period has arithmetic mean of 1.55. The median price for the last 90 days is 1.54. The company completed stock split (1:8) on 30th of September 2024. Sonnet Biotherapeutics had dividends distributed to its stock-holders on 2020-04-02.
OpenHighLowCloseVolume
03/27/2025
 1.40  1.41  1.33  1.36 
03/25/2025 1.40  1.41  1.33  1.36  20,880 
03/24/2025 1.39  1.42  1.34  1.40  31,408 
03/21/2025 1.36  1.42  1.33  1.38  66,899 
03/20/2025 1.37  1.46  1.35  1.43  19,398 
03/19/2025 1.39  1.47  1.35  1.40  122,701 
03/18/2025 1.38  1.39  1.33  1.39  14,581 
03/17/2025 1.35  1.39  1.34  1.39  29,474 
03/14/2025 1.39  1.39  1.30  1.36  11,444 
03/13/2025 1.39  1.43  1.32  1.32  29,711 
03/12/2025 1.40  1.41  1.35  1.39  13,536 
03/11/2025 1.43  1.43  1.35  1.39  16,243 
03/10/2025 1.51  1.52  1.40  1.40  44,507 
03/07/2025 1.49  1.50  1.44  1.49  27,484 
03/06/2025 1.43  1.48  1.43  1.44  15,090 
03/05/2025 1.39  1.54  1.38  1.46  42,489 
03/04/2025 1.47  1.50  1.30  1.45  111,741 
03/03/2025 1.52  1.55  1.50  1.51  26,201 
02/28/2025 1.51  1.55  1.48  1.55  29,661 
02/27/2025 1.50  1.55  1.50  1.54  29,360 
02/26/2025 1.51  1.57  1.46  1.52  82,883 
02/25/2025 1.51  1.53  1.44  1.50  24,723 
02/24/2025 1.41  1.55  1.39  1.51  115,858 
02/21/2025 1.44  1.46  1.38  1.44  67,880 
02/20/2025 1.50  1.50  1.41  1.43  54,116 
02/19/2025 1.50  1.53  1.38  1.50  426,082 
02/18/2025 1.59  1.59  1.50  1.53  39,810 
02/14/2025 1.57  1.60  1.54  1.59  47,430 
02/13/2025 1.51  1.55  1.51  1.54  31,398 
02/12/2025 1.57  1.60  1.50  1.56  69,202 
02/11/2025 1.58  1.64  1.55  1.57  101,919 
02/10/2025 1.62  1.66  1.55  1.59  43,990 
02/07/2025 1.58  1.62  1.55  1.59  47,503 
02/06/2025 1.65  1.69  1.61  1.62  32,310 
02/05/2025 1.60  1.67  1.57  1.64  49,475 
02/04/2025 1.57  1.65  1.55  1.62  44,930 
02/03/2025 1.60  1.64  1.53  1.59  50,333 
01/31/2025 1.72  1.75  1.62  1.65  55,780 
01/30/2025 1.69  1.75  1.67  1.73  49,290 
01/29/2025 1.69  1.87  1.66  1.69  73,080 
01/28/2025 1.81  1.91  1.64  1.73  224,354 
01/27/2025 1.81  1.93  1.73  1.81  146,168 
01/24/2025 1.70  1.93  1.70  1.83  316,668 
01/23/2025 1.79  1.85  1.64  1.71  384,300 
01/22/2025 1.58  2.05  1.53  2.00  1,084,350 
01/21/2025 1.49  1.56  1.44  1.54  452,030 
01/17/2025 1.55  1.57  1.50  1.54  67,088 
01/16/2025 1.52  1.58  1.50  1.54  73,244 
01/15/2025 1.53  1.58  1.46  1.52  63,660 
01/14/2025 1.60  1.60  1.50  1.52  108,745 
01/13/2025 1.60  1.60  1.53  1.58  117,118 
01/10/2025 1.59  1.61  1.51  1.58  111,614 
01/08/2025 1.76  1.76  1.51  1.55  281,016 
01/07/2025 1.94  1.99  1.72  1.78  321,855 
01/06/2025 1.75  2.52  1.75  1.90  1,668,903 
01/03/2025 1.60  1.80  1.60  1.75  323,962 
01/02/2025 1.46  1.73  1.46  1.60  290,471 
12/31/2024 1.50  1.54  1.45  1.46  145,352 
12/30/2024 1.51  1.53  1.45  1.48  94,927 
12/27/2024 1.51  1.54  1.44  1.51  157,738 
12/26/2024 1.45  1.52  1.43  1.49  280,945 

About Sonnet Biotherapeutics Stock history

Sonnet Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sonnet is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sonnet Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sonnet Biotherapeutics stock prices may prove useful in developing a viable investing in Sonnet Biotherapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding 439.58  417.60 
Net Loss-16.1 M-16.9 M

Sonnet Biotherapeutics Stock Technical Analysis

Sonnet Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sonnet Biotherapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sonnet Biotherapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Investing Opportunities Now

   

Investing Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module

Sonnet Biotherapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Sonnet Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Sonnet Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sonnet to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.22)
Revenue Per Share
0.959
Quarterly Revenue Growth
52.688
Return On Assets
(1.34)
Return On Equity
(2.85)
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.